Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: toccodolce who wrote (7793)	10/6/2001 3:06:43 PM
From: Mark Bartlett	Read Replies (1) \| Respond to of 14101

Thomas, That approval was granted about 2-3 years ago. The problem with a Thailand approval is that only the wealthy can afford the drug -- so well there may be 62 million people, for the vast majority the drug is way out of reach. Oxo started their trials there many years ago, so I suspect that is the reason that they received that approval. MB

To: toccodolce who wrote (7793)	10/7/2001 1:33:20 AM
From: Cal Gary	Respond to of 14101

Hi Thomas, I'm not a financial accountant so I don't know the rules for consolidations and % equity ownership. Perhaps an accountant can help. I do know that DMX has expensed all research monies and in the past Q4 has expensed all OXO items pertaining to Canadian marketing rights.

To: toccodolce who wrote (7793)	10/7/2001 9:11:07 AM
From: Ron Nairn	Respond to of 14101

Thomas, you asked...So if Dmx owns 20% of OXO Chemie, are they allowed to report 20% of OXO Chemie's earnings or revenue to DMX's bottom line? Minority ownership of a corporation with profits does not equate to distribution. Oxo's revenue is it's alone, for it's use, unless it distrubutes. As OXO is not a publicly held corporation, it is not obliged to even publish it's results. Now, when it is 100% consolidated into DMX, certainly we'll be privy to all that info on an ongoing basis. Rondo

To: toccodolce who wrote (7793)	10/7/2001 7:10:03 PM
From: PlayTheKing	Read Replies (1) \| Respond to of 14101

Thomas: Under current Canadian GAAP rules 20% ownership is a "grey area" that allows companies to either record the investment in one of 2 ways: 1) Cost 2) Proportionate consolidation The deciding factor as to which two methods is selected depends on whether DMX exercises significant influence over Oxo. If it does, then option 2 has to be followed which means that DMX would record its "proportionate share" of Oxo revenues, expenses, assets etc. Any income (loss) would increase (decrease) DMX's reported investment in Oxo. If it doesn't exercise significant influence then DMX would record the investment at cost with the only income coming by way of interest/dividends. All of this will now be irrelevant as DMX has proposed to acquire 100% of Oxo giving it "control" over Oxo. When this is approved, Canadian GAAP requires that DMX consolidate the operations of Oxo into DMX's financial results. Hope that helps. PlayTheKing